Emerging data for the management of respiratory tract infections, ERS virtual congress 2021

Respiratory medicine meets other disciplines, 07.09.2021

A joint ERS/ESCMID session. Results from the current European Clinical Research Initiative on Antimicrobial resistance and emerging Infectious Diseases (ECRAID) - Value-Dx project

Chairs: G. Sotgiu (Porto Torres (SS), Italy), M. Barrecheguren Fernandez (Barcelona, Spain)
Aims: To present the first data emerging from the European project of Value Dx aimed at investigating the use of old and new diagnostic tests to optimise the use of antimicrobials and the management of respiratory infections across different settings (from primary care to intensive care units); to provide an overview and update of the role of diagnostics in the management of respiratory infections by reducing the overuse of antimicrobials and optimising clinical outcomes, utilisation of healthcare resources and economics. The Value Dx project is part of the European clinical research initiative on antimicrobial resistance and emerging infectious diseases.


Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia
M. Sanguinetti (Rome, Italy)
WebcastSlide presentation
WebcastSlide presentation
Use of diagnostic tests in respiratory tract infections: an economic analysis.
M. Postma (Groningen, Netherlands)
WebcastSlide presentation
WebcastSlide presentation
Management of community-acquired pneumonia: new evidence-based algorithms.
E. Tacconelli (Italy)
WebcastSlide presentation
WebcastSlide presentation
Are antimicrobials still the future of respiratory infection therapy?
S. Aliberti (Milano (MI), Italy)
WebcastSlide presentation
WebcastSlide presentation
Discussion and Q&A

Webcast
Webcast